The US DoJ Antitrust Division enters into a rare deferred prosecution agreement, and a first one with a company that is not a bank (Heritage Pharmaceuticals)

The Department of Justice (DOJ) routinely relies on deferred prosecution agreements (DPAs) and non-prosecution agreements (NPAs) to resolve corporate criminal investigations. Since 2004, the DOJ has entered into an average of 33 such agreements per year. These agreements allow companies to avoid what can be cataclysmic consequences of pleading guilty. From the government’s perspective, they provide an admission of wrongdoing, cooperation with the investigation, payment of a fine, and assurance of an improvement of a company’s compliance program. While DPAs and NPAs are popular among the DOJ’s Criminal Division and US Attorneys’ offices around the country, the DOJ’s Antitrust Division has been very reluctant to enter into such agreements, believing that they undercut the division’s unique

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteurs

  • Baker Botts (San Francisco)
  • Baker Botts (Washington)

Citation

Peter Huston, Alex Bourelly, The US DoJ Antitrust Division enters into a rare deferred prosecution agreement, and a first one with a company that is not a bank (Heritage Pharmaceuticals), 31 mai 2019, e-Competitions May 2019, Art. N° 94484

Visites 24

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues